Genetic variants in the promoter region of the ALOx5AP gene and susceptibility of ischemic stroke

Cerebrovascular Diseases

Volumn 32, Issue 3, 2011, Pages 261-268

  Ji, Ruijun ^a   Jia, Jianping ^a   Ma, Xin ^a   Wu, Jian ^a   Zhang, Yanli ^a   Xu, Liqing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Gene; Ischemic stroke; Polymorphism; Susceptibility

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; LEUKOTRIENE B4;

AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

5-LIPOXYGENASE-ACTIVATING PROTEINS; AGED; ANALYSIS OF VARIANCE; BASE SEQUENCE; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOTRIENE B4; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 80052315538     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000330341     Document Type: Article

References (38)

1. Funk CD: Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 2001; 294: 1871-1875. (Pubitemid 33101574)
2. Funk CD: Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat Rev Drug Discov 2005; 4: 664-672. (Pubitemid 41149760)
3. Lotzer K, Funk CD, Habenicht AJ: The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochim Biophys Acta 2005; 1736: 30-37. (Pubitemid 41208257)
4. Dixon RA, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK: Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 1990; 343: 282-284.
5. Miller DK, Gillard JW, Vickers PJ, et al: Identification and isolation of a membrane protein necessary for leukotriene production. Nature 1990; 343: 278-281.
6. Zhao L, Funk CD: Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med 2004; 14: 191-195. (Pubitemid 38942827)
7. Helgadottir A, Manolescu A, Thorleifsson G, et al: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004; 36: 233-239. (Pubitemid 38282747)
8. Helgadottir A, Gretarsdottir S, St Clair D, Manolescu A, Cheung J, Thorleifsson G, Pasdar A, Grant SF, Whalley LJ, Hakonarson H, Thorsteinsdottir U, Kong A, Gulcher J, Stefansson K, MacLeod MJ: Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 2005; 76: 505-509. (Pubitemid 40250529)
9. Meschia JF, Brott TG, Brown RD Jr, et al: Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol 2005; 58: 351-361. (Pubitemid 41266621)
10. Lohmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G, Meitinger T, Dichgans M: ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005; 36: 731-736.
11. Zee RY, Cheng S, Hegener HH, Erlich HA, Ridker PM: Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: A nested case-control approach. Stroke 2006; 37: 2007-2011. (Pubitemid 44309895)
12. Zhang WL, Yang XM, Shi J, Sun K, Hui RT: Polymorphism of sg13s114t/a in the ALOX5AP gene and the risk for stroke in a large Chinese cohort. Yi Chuan Xue Bao 2006; 33: 678-684.
13. Kostulas K, Gretarsdottir S, Kostulas V, Manolescu A, Helgadottir A, Thorleifsson G, Gudmundsson LJ, Thorsteinsdottir U, Gulcher JR, Stefansson K, Hillert J: PDE4D and ALOX5AP genetic variants and risk for ischemic cerebrovascular disease in Sweden. J Neurol Sci 2007; 263: 113-117. (Pubitemid 350029850)
14. Shen CD, Zhang WL, Sun K, Wang YB, Zhen YS, Hui RT: Interaction of genetic risk factors confers higher risk for thrombotic stroke in male Chinese: A multicenter casecontrol study. Ann Hum Genet 2007; 71: 620-629. (Pubitemid 47087070)
15. Kaushal R, Pal P, Alwell K, Haverbusch M, Flaherty M, Moomaw C, Sekar P, Kissela B, Kleindorfer D, Chakraborty R, Broderick J, Deka R, Woo D: Association of ALOX5AP with ischemic stroke: A population-based case-control. Hum Genet 2007; 121: 601-607. (Pubitemid 46706071)
16. Bevan S, Dichgans M, Wiechmann HE, Gschwendtner A, Meitinger T, Markus HS: Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: A replication study in two independent populations. Stroke 2008; 39: 1109-1114. (Pubitemid 351440677)
17. Assimes TL, Knowles JW, Priest JR, et al: Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet 2008; 123: 399-408.
18. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M: Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004; 350: 29-37. (Pubitemid 38032181)
19. van der Net JB, Versmissen J, Oosterveer DM, Defesche JC, Yazdanpanah M, Aouizerat BE, Steyerberg EW, Malloy MJ, Pullinger CR, Kane JP, Kastelein JJ, Sijbrands EJ: Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia. Atherosclerosis 2009; 203: 472-478.
20. Domingues-Montanari S, Fernandez-Cadenas I, del Rio-Espinola A, et al: Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: A case-control, meta-analysis and functional study. Cerebrovasc Dis 2010; 29: 528-537.
21. Tsai AK, Li N, Hanson NQ, Tsai MY, Tang W: Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population. Atherosclerosis 2009; 207: 487-491.
22. Linsel-Nitschke P, Gotz A, Medack A, Konig IR, Bruse P, Lieb W, Mayer B, Stark K, Hengstenberg C, Fischer M, Baessler A, Ziegler A, Schunkert H, Erdmann J: Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population. Clin Sci (Lond) 2008; 115: 309-315.
23. Bevan S, Lorenz MW, Sitzer M, Markus HS: Genetic variation in the leukotriene path -way and carotid intima-media thickness: A 2-stage replication study. Stroke 2009; 40: 696-701.
24. Zintzaras E, Rodopoulou P, Sakellaridis N: Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: A huge gene-disease association review and meta-analysis. Am J Epidemiol 2009; 169: 523-532.
25. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial -TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41. (Pubitemid 23014379)
26. Kennedy BP, Diehl RE, Boie Y, Adam M, Dixon RA: Gene characterization and promoter analysis of the human 5-lipoxygenase-activating protein (FLAP). J Biol Chem 1991; 266: 8511-8516. (Pubitemid 21906539)
27. Skol AD, Scott LJ, Abecasis GR, Boehnke M: Joint analysis is more efficient than replication-based analysis for two-stage genomewide association studies. Nat Genet 2006; 38: 209-213. (Pubitemid 43177235)
28. Narlikar GJ, Fan HY, Kingston RE: Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002; 108: 475-487. (Pubitemid 34260873)
29. Xu L, Glass CK, Rosenfeld MG: Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 1999; 9: 140-147. (Pubitemid 29158546)
30. Mills RE, Luttig CT, Larkins CE, Beauchamp A, Tsui C, Pittard WS, Devine SE: An initial map of insertion and deletion (INDEL) variation in the human genome. Genome Res 2006; 16: 1182-1190. (Pubitemid 44320405)
31. Berger J, Suzuki T, Senti KA, Stubbs J, Schaffner G, Dickson BJ: Genetic mapping with SNP markers in Drosophila Nat Genet 2001; 29: 475-481. (Pubitemid 34326701)
32. Dawson E, Chen Y, Hunt S, Smink LJ, Hunt A, Rice K, Livingston S, Bumpstead S, Bruskiewich R, Sham P, Ganske R, Adams M, Kawasaki K, Shimizu N, Minoshima S, Roe B, Bentley D, Dunham I: A SNP resource for human chromosome 22: Extracting dense clusters of SNPs from the genomic sequence. Genome Res 2001; 11: 170-178. (Pubitemid 32117963)
33. Thameem F, Voruganti VS, He X, Nath SD, Blangero J, MacCluer JW, Comuzzie AG, Abboud HE, Arar NH: Genetic variants in the renin-angiotensin system genes are associated with cardiovascular-renal-related risk factors in Mexican Americans. Hum Genet 2008; 124: 557-559.
34. Niu W, Qi Y, Gao P, Zhu D: Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: Evidence from a meta-analysis. Endocr J 2010; 57: 431-438.
35. Funada A, Konno T, Fujino N, Muramoto A, Hayashi K, Tsubokawa T, Sakata K, Kawashiri MA, Takeda Y, Ino H, Yamagishi M: Impact of renin-angiotensin system polymorphisms on development of systolic dysfunction in hypertrophic cardiomyopathy: Evidence from a study of genotyped patients. Circ J 2010; 74: 2674-2680.
36. Vaisi-Raygani A, Ghaneialvar H, Rahimi Z, Nomani H, Saidi M, Bahrehmand F, Tavilani H, Pourmotabbed T: The angiotensin converting enzyme D allele is an independent risk factor for early onset coronary artery disease. Clin Biochem 2010; 43: 1189-1194.
37. Pongracz E, Tordai A, Csornai M, Nagy Z: Investigation of insertion/deletion polymorphism of the ACE gene in stroke patients. Ideggyogy Sz 2002; 55: 157-163.
38. Tascilar N, Dursun A, Ankarali H, Mungan G, Ekem S, Baris S: Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertension. J Neurol Sci 2009; 285: 137-141.